DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Patent 6,310,094 protects ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER, BREVIBLOC, BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, and BREVIBLOC IN PLASTIC CONTAINER, and is included in two NDAs.
Protection for BREVIBLOC has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in twenty-five countries.
Summary for Patent: 6,310,094
|Title:||Ready-to-use esmolol solution|
|Abstract:||A ready-to-use injectable, aqueous pharmaceutical composition for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture in a container, is disclosed.|
|Inventor(s):||Liu; Jie (Scotch Plains, NJ), Pejaver; Satish K. (Bridgewater, NJ), Owoo; George (North Plainfield, NJ)|
|Assignee:||Baxter International Inc. (Deerfield, IL)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 6,310,094|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Formulation; Process;|
|Country||Patent Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Argentina||035416||⤷ Free Forever Trial|
|Argentina||098013||⤷ Free Forever Trial|
|Austria||341319||⤷ Free Forever Trial|
|Australia||2002309475||⤷ Free Forever Trial|
|>Country||>Patent Number||>Estimated Expiration||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration|